Type 2 Diabetes
![better therapeutics type 2 diabetes, better therapeutics digital app, type 2 diabetes management, better therapeutics news, digital health company, type 2 diabetes app, better therapeutics launch,](https://pharmtales.com/wp-content/uploads/2023/10/Better-Therapeutics-launches-digital-app-to-help-Type-2-diabetes-patients.jpg)
Better Therapeutics launches digital app to help Type 2 diabetes patients
Anika Sharma
Better Therapeutics is officially launching its digital therapeutic app, AspyreRx, for managing Type 2 diabetes after securing FDA de novo ...
![Dexcom CGMs Clinch Victories in Type 2 Diabetes and Pregnancy at EASD Conference](https://pharmtales.com/wp-content/uploads/2023/10/Dexcom-CGMs-Clinch-Victories-in-Type-2-Diabetes-and-Pregnancy-at-EASD-Conference.jpg)
Dexcom CGMs Clinch Victories in Type 2 Diabetes and Pregnancy at EASD Conference
Anika Sharma
In the realm of continuous glucose monitors (CGMs), recent discussions have revolved around broadening their application beyond the traditional user ...
![National Health Service, Eli Lilly, Mounjaro, National Institute for Health and Care Excellence, NICE recommendation, Type 2 diabetes](https://pharmtales.com/wp-content/uploads/2023/09/Eli-Lillys-Mounjaro-gets-NICE-approval-for-type-2-diabetes-after-cost-effectiveness-review.jpg)
Eli Lillyâs Mounjaro gets NICE approval for type 2 diabetes after cost-effectiveness review
Anika Sharma
Eli Lilly’s diabetes medication, Mounjaro (tirzepatide), has been on a winning streak since its US launch in May, and now ...
![The US FDA has approved the use of Jardiance (empagliflozin) to treat type II diabetes in children and adolescents aged 10 and older](https://pharmtales.com/wp-content/uploads/2023/06/The-US-FDA-has-approved-the-use-of-Jardiance-empagliflozin-to-treat-type-II-diabetes-in-children-and-adolescents-aged-10-and-older.jpg)
The US FDA has approved the use of Jardiance (empagliflozin) to treat type II diabetes in children and adolescents aged 10 and older
SG Tylor
Source – Eli Lilly On June 21, 2023, Boehringer Ingelheim and Eli Lilly and Company announced that the US Food ...